Your browser doesn't support javascript.
Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.
Marwali, Eva Miranda; Kekalih, Aria; Yuliarto, Saptadi; Wati, Dyah Kanya; Rayhan, Muhammad; Valerie, Ivy Cerelia; Cho, Hwa Jin; Jassat, Waasila; Blumberg, Lucille; Masha, Maureen; Semple, Calum; Swann, Olivia V; Kohns Vasconcelos, Malte; Popielska, Jolanta; Murthy, Srinivas; Fowler, Robert A; Guerguerian, Anne-Marie; Streinu-Cercel, Anca; Pathmanathan, Mohan Dass; Rojek, Amanda; Kartsonaki, Christiana; Gonçalves, Bronner P; Citarella, Barbara Wanjiru; Merson, Laura; Olliaro, Piero L; Dalton, Heidi Jean.
  • Marwali EM; Department of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia eva.marwali@pjnhk.go.id.
  • Kekalih A; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
  • Yuliarto S; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Wati DK; Department of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar Hospital, Malang, Jawa Timur, Indonesia.
  • Rayhan M; Department of Pediatrics, Faculty of Medicine, Universitas Udayana, Sanglah Hospital, Denpasar, Bali, Indonesia.
  • Valerie IC; Department of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
  • Cho HJ; Department of Pediatrics, Faculty of Medicine, Universitas Udayana, Sanglah Hospital, Denpasar, Bali, Indonesia.
  • Jassat W; Division of Pediatric Cardiology and Pediatric Intensive Care, Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea (the Republic of).
  • Blumberg L; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Masha M; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Semple C; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Swann OV; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
  • Kohns Vasconcelos M; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool, Merseyside, UK.
  • Popielska J; Centre for Medical Informatics, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Murthy S; Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Fowler RA; Warsaw's Hospital for Infectious Diseases, Medical University of Warsaw, Warszawa, Mazowieckie, Poland.
  • Guerguerian AM; Department of Pediatrics, Division of Critical Care, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Streinu-Cercel A; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Pathmanathan MD; Department of Critical Care Medicine, Neurosciences and Mental Health Program, Faculty of Medicine, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Rojek A; National Institute of Infectious Diseases Prof Dr Matei Bals, Bucuresti, Romania.
  • Kartsonaki C; National Institutes of Health, Ministry of Health Malaysia, Putrajaya, Wilayah Persekutuan, Malaysia.
  • Gonçalves BP; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
  • Citarella BW; The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Merson L; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
  • Olliaro PL; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
  • Dalton HJ; International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
BMJ Paediatr Open ; 6(1)2022 10.
Article in English | MEDLINE | ID: covidwho-2153006
ABSTRACT

BACKGROUND:

The impact of the COVID-19 pandemic on paediatric populations varied between high-income countries (HICs) versus low-income to middle-income countries (LMICs). We sought to investigate differences in paediatric clinical outcomes and identify factors contributing to disparity between countries.

METHODS:

The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database was queried to include children under 19 years of age admitted to hospital from January 2020 to April 2021 with suspected or confirmed COVID-19 diagnosis. Univariate and multivariable analysis of contributing factors for mortality were assessed by country group (HICs vs LMICs) as defined by the World Bank criteria.

RESULTS:

A total of 12 860 children (3819 from 21 HICs and 9041 from 15 LMICs) participated in this study. Of these, 8961 were laboratory-confirmed and 3899 suspected COVID-19 cases. About 52% of LMICs children were black, and more than 40% were infants and adolescent. Overall in-hospital mortality rate (95% CI) was 3.3% [=(3.0% to 3.6%), higher in LMICs than HICs (4.0% (3.6% to 4.4%) and 1.7% (1.3% to 2.1%), respectively). There were significant differences between country income groups in intervention profile, with higher use of antibiotics, antivirals, corticosteroids, prone positioning, high flow nasal cannula, non-invasive and invasive mechanical ventilation in HICs. Out of the 439 mechanically ventilated children, mortality occurred in 106 (24.1%) subjects, which was higher in LMICs than HICs (89 (43.6%) vs 17 (7.2%) respectively). Pre-existing infectious comorbidities (tuberculosis and HIV) and some complications (bacterial pneumonia, acute respiratory distress syndrome and myocarditis) were significantly higher in LMICs compared with HICs. On multivariable analysis, LMIC as country income group was associated with increased risk of mortality (adjusted HR 4.73 (3.16 to 7.10)).

CONCLUSION:

Mortality and morbidities were higher in LMICs than HICs, and it may be attributable to differences in patient demographics, complications and access to supportive and treatment modalities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Child / Humans Language: English Year: 2022 Document Type: Article Affiliation country: Bmjpo-2022-001657

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Child / Humans Language: English Year: 2022 Document Type: Article Affiliation country: Bmjpo-2022-001657